Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe

We report two cases of dolutegravir (DTG) resistance in highly treatment experienced patients. Monitoring for treatment failure and adherence support is important in highly treatment experienced patients taking DTG. WHAT THIS STUDY ADDS: Dolutegravir is the mainstay of HIV treatment programmes and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandikiyana Chirimuta, Linda A., Pascoe, Margaret J., Lowe, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634947/
https://www.ncbi.nlm.nih.gov/pubmed/36479423
http://dx.doi.org/10.4102/sajhivmed.v23i1.1435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634947/
https://www.ncbi.nlm.nih.gov/pubmed/36479423
http://dx.doi.org/10.4102/sajhivmed.v23i1.1435

Ejemplares similares